Innoviz (INVZ) CBO Elad Hofstetter Receives RSUs & Options

What Happened Elad Ben Hofstetter, Chief Business Officer of Innoviz Technologies Ltd. (INVZ), received equity awards on August 4, 2026: 54,112 Restricted Share Units (RSUs) and 57,968 share options. Both awards were reported as acquisitions on Form 4 at $0.00 (no cash paid). The RSUs and options vest over time — one-fourth on August 4, 2027, with the remainder vesting quarterly through 2030 — and vesting is contingent on continued service to the company.

Key Details

• Transaction date(s): August 4, 2026; Form 4 filed August 5, 2026 (timely).
• Awards reported: 54,112 RSUs (acquired at $0.00) and 57,968 share options (reported as derivative acquisition at $0.00).
• Vesting: One-fourth on Aug 4, 2027; remaining awards vest quarterly through 2030 (subject to continued service).
• Shares owned/issuable after transaction: filing states 176,964 ordinary shares issuable upon vesting of outstanding RSUs (this total includes the new 54,112 RSUs).
• Footnotes: RSUs represent contingent rights to receive one ordinary share with no exercise price. Options were also granted on Aug 4, 2026 with the same vesting schedule; filing does not disclose an exercise price in the provided footnotes.
• Filing timeliness: Filed the next day (no late filing flag).

Context

• These transactions are awards/grants (code A), not open-market purchases or sales — they increase potential future ownership if vesting conditions are met and do not indicate immediate cash proceeds.
• RSUs convert to shares upon vesting (no exercise required); options will require exercise (exercise price not stated in the provided notes).
• Such time‑based grants are common for executive retention and align pay with future service; they are informational rather than a direct buy/sell signal for the market.